how long to take ghk cu peptide GHK-Cu Scalp Solution GHK-Cu: The Copper Peptide for

Expected Timeline and Realistic Outcomes Setting realistic expectations helps maintain consistency throughout a BPC-157 protocol

BPC-157 is not FDA-approved for human use and requires a prescription from a licensed provider to be dispensed from a US compounding pharmacy

Users stopping niacinamide typically experience very gradual benefit decline over 1-3 months without dramatic reversal, maintaining 40-60% of improvements long-term if treatment lasted 6+ months, and tolerating breaks or cycling without rebound effects or significant regression concerns

Product Contamination: Quality control is a serious concern for unregulated BPC-157, as vials purchased on the gray market may contain questionable purity levels, degraded compounds, or peptide variants without any oversight

Week 24 Primary effects begin to manifest

10.1038/s41467-019-10449-w 156 NikiforukA.KalabaP.IlicM.KorzV.DragaeviV.WackerligJ.et al (2017)